Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Goeteborg, Sweden Clinical Trials

A listing of Goeteborg, Sweden clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

To evaluate safety and the effect of isolated limb perfusion together with nivolumab as a way to increase efficacy and give further insights in early immunological mechanisms. In the first phase Ib part, 20 patients will be enrolled and followed for a minimum of 3 months. An independent data safety …

Phase

0.0 miles

Learn More »

A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

Enrolled subjects will receive histamine dihydrochloride (HDC; Ceplene) and/or IL-2 (Proleukin) subcutaneously (s.c.) twice daily (BID) in 3-week periods followed by 3- or 6 week rest periods. All subjects will be assigned to one of three consecutive cohorts, each comprising five patients. Cohort 1 will receive HDC without IL-2 for …

Phase

0.0 miles

Learn More »

Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML) a Cancer of the Blood

The medical condition being investigated is relapsed or refractory AML in participants aged 1 month to 21 years with Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutations (FLT3-ITD AML), following failure of front-line intensive chemotherapy. The trial will be conducted in multiple phases. An independent data …

Phase

0.0 miles

Learn More »

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04)

This is a Phase 1/2a, multicenter, dose-finding, consecutive-cohort, open-label trial of BI-1206 in combination with pembrolizumab in subjects with advanced solid tumors who have previously received treatment with a PD-1/PD-L1 immune checkpoint inhibitor. The trial will consist of 2 main parts: Phase 1 (with dose escalation cohorts and selection of …

Phase

0.0 miles

Learn More »